AnaptysBio Inc. Revenue 2015–2025
AnaptysBio Inc. annual/quarterly revenue history and growth rate from 2015 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- AnaptysBio Inc. revenue for the quarter ending March 31, 2026 was 25.6 M, a 7.98% decrease year-over-year.
- AnaptysBio Inc. revenue for the twelve months ending March 31, 2026 was 151.9 M, a 195.06% increase year-over-year.
- AnaptysBio Inc. annual revenue for 2025 was 234.6 M, a 157.01% increase from 2024.
- AnaptysBio Inc. annual revenue for 2024 was 91.3 M, a 432.03% increase from 2023.
- AnaptysBio Inc. annual revenue for 2023 was 17.2 M, a 66.78% increase from 2022.
- AnaptysBio Inc. annual revenue for 2022 was 10.3 M.
AnaptysBio Inc. (ANAB) — Frequently Asked Questions
AnaptysBio Inc. (ANAB) is a publicly traded US company. It has a market capitalization of $1.54B. In fiscal 2025 it reported revenue of $235M and net income of -$13M. Explore ANAB's stock price, financial statements, earnings history, margins and key ratios below.
What is AnaptysBio Inc.'s market cap?
AnaptysBio Inc. (ANAB) has a market capitalization of $1.54B.
What is the ANAB stock price?
ANAB trades at $53.70 (+3.06% on the day).
How much revenue does AnaptysBio Inc. make?
AnaptysBio Inc. reported revenue of $235M in fiscal 2025.
Is ANAB profitable?
In fiscal 2025, AnaptysBio Inc. reported net income of -$13M.